Table 4. MDD diagnosis of patients undergoing TBCB.
| MDD diagnosis | Case (%) |
|---|---|
| CTD-ILD | 89 (23.9) |
| IPF | 33 (8.8) |
| INSIP | 7 (1.9) |
| COP | 7 (1.9) |
| PAP | 15 (4.0) |
| PAM | 10 (2.7) |
| Lung cancer | 18 (4.8) |
| Pneumonia | 11 (2.9) |
| HP | 6 (1.6) |
| Sarcoidosis | 5 (1.3) |
| Pneumoconiosis | 5 (1.3) |
| Desquamative interstitial pneumonia | 4 (1.1) |
| TB | 4 (1.1) |
| Emphysema | 4 (1.1) |
| RB-ILD | 3 (0.8) |
| ACFE | 2 (0.5) |
| PCP | 1 (0.3) |
| PLCH | 1 (0.3) |
| PAM | 1 (0.3) |
| Cryptococcosis | 1 (0.3) |
| Occupational-related pneumonia | 1 (0.3) |
| Radiation pneumonia | 1 (0.3) |
| Diffuse large B lymphoma in pulmonary vessels | 1 (0.3) |
| Giant cell interstitial pneumonia | 1 (0.3) |
| Lipid pneumonia | 1 (0.3) |
| IPH | 1 (0.3) |
| PIE | 1 (0.3) |
| PO | 1 (0.3) |
| DR-ILD | 1 (0.3) |
| Aspiration pneumonia | 1 (0.3) |
| ND | 136 (36.5) |
MDD, multidisciplinary discussion; CTD, connective tissue disease; ILD, interstitial lung disease; IPF, idiopathic pulmonary fibrosis; iNSIP, idiopathic non-specific interstitial pneumonia; ACFE, airway-centered fibroelastosis; COP, cryptogenic organizing pneumonia; PAP, pulmonary alveolar proteinosis; PLAM, pulmonary lymphangiomyomatosis; HP, hypersensitivity pneumonitis; DIP, desquamative interstitial pneumonia; PCP, pneumocystis pneumonia; PLCH, pulmonary Langerhans cell histiocytosis; RB-ILD, respiratory bronchiolitis-interstitial lung disease; TB, tuberculosis; PAM, pulmonary alveolar microlithiasis; PO, pulmonary ossification; IPH, idiopathic pulmonary hemosiderosis; DR-ILD, drug-related interstitial lung disease.